FORMULARY CONTROL OF ANTIMICROBIAL USAGE - WHAT PRICE FREEDOM

被引:41
作者
DUNAGAN, WC
MEDOFF, G
机构
[1] Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO
关键词
D O I
10.1016/0732-8893(93)90120-V
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Formulary controls are the most common and probably the most effective method for controlling abuse of antimicrobial agents in hospitalized patients, Such programs may include restriction of both the number of agents available and the way these agents may be used. These programs have been demonstrated to control pharmacy expenditures. Other potential advantages include reductions in the incidence of adverse drug reactions and the antimicrobial resistance among the hospital flora, and improvements in the overall quality of prescribing of antimicrobials. There are few data to document such benefits, however. Potential disadvantages are also poorly documented but include inconvenience for prescribing physicians, increased administrative costs, prescribing errors, and increased antimicrobial resistance. Antimicrobial control programs will likely remain common, but the availability of new information technologies should enable a transition to systems based on concurrent assessment of antimicrobial appropriateness with immediate feedback to the prescribing physician.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 25 条
  • [1] USE OF CLINICAL PHARMACISTS TO REDUCE CEFAMANDOLE, CEFOXITIN, AND TICARCILLIN COSTS
    ABRAMOWITZ, PW
    NOLD, EG
    HATFIELD, SM
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1982, 39 (07): : 1176 - 1180
  • [2] ACHONG MR, 1977, CAN MED ASSOC J, V116, P256
  • [3] Buchanan B G., 1984, RULE BASED EXPERT SY
  • [4] HOSPITAL USE OF ANTI-MICROBIAL DRUGS - SURVEY AT 19 HOSPITALS AND RESULTS OF ANTI-MICROBIAL CONTROL PROGRAM
    CRAIG, WA
    UMAN, SJ
    SHAW, WR
    RAMGOPAL, V
    EAGAN, LL
    LEOPOLD, ET
    [J]. ANNALS OF INTERNAL MEDICINE, 1978, 89 (05) : 793 - 795
  • [5] DOES ACCEPTING PHARMACOKINETIC RECOMMENDATIONS IMPACT HOSPITALIZATION - A COST-BENEFIT-ANALYSIS
    DESTACHE, CJ
    MEYER, SK
    ROWLEY, KM
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (05) : 427 - 433
  • [6] DUNAGAN WC, 1991, REV INFECT DIS, V13, P405
  • [7] COMPUTER SURVEILLANCE OF HOSPITAL-ACQUIRED INFECTIONS AND ANTIBIOTIC USE
    EVANS, RS
    LARSEN, RA
    BURKE, JP
    GARDNER, RM
    MEIER, FA
    JACOBSON, JA
    CONTI, MT
    JACOBSON, JT
    HULSE, RK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (08): : 1007 - 1011
  • [8] CONTROLLING CEPHALOSPORIN AND AMINOGLYCOSIDE COSTS THROUGH PHARMACY AND THERAPEUTICS COMMITTEE RESTRICTIONS
    HAYMAN, JN
    SBRAVATI, EC
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (06): : 1343 - 1347
  • [9] INTEGRATION OF CLINICAL AND ADMINISTRATIVE STRATEGIES TO REDUCE EXPENDITURES FOR ANTIMICROBIAL AGENTS
    HESS, DA
    MAHONEY, CD
    JOHNSON, PN
    CORRAO, WM
    FISHER, AE
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03): : 585 - 591
  • [10] USE OF ANTIMICROBIAL AGENTS IN A UNIVERSITY TEACHING HOSPITAL - EVOLUTION OF A COMPREHENSIVE CONTROL PROGRAM
    HIRSCHMAN, SZ
    MEYERS, BR
    BRADBURY, K
    MEHL, B
    GENDELMAN, S
    KIMELBLATT, B
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) : 2001 - 2007